Short Hills, NJ, United States of America

Peter Ronald Young

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Ronald Young

Introduction

Peter Ronald Young is a notable inventor based in Short Hills, New Jersey. He has made significant contributions to the field of medical research, particularly in the treatment of neurological diseases and cancer. His innovative approach combines existing therapies to enhance treatment efficacy.

Latest Patents

Peter Ronald Young holds a patent for a groundbreaking invention titled "Combination therapy with apilimod and glutamatergic agents." This patent provides compositions and methods related to the use of apilimod in combination with glutamatergic agents for treating neurological diseases and disorders, as well as for the treatment of cancer. This innovative therapy aims to improve patient outcomes through a synergistic approach.

Career Highlights

Throughout his career, Peter has demonstrated a commitment to advancing medical science. His work at Orphal Therapeutics Inc. has positioned him as a key player in the development of novel therapeutic strategies. His dedication to research and innovation has led to significant advancements in the treatment of complex diseases.

Collaborations

Peter Ronald Young has collaborated with esteemed colleagues such as Henri Lichenstein and Sean Landrette. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately enhancing the quality of research and development.

Conclusion

Peter Ronald Young's contributions to the field of medical research exemplify the impact of innovative thinking in addressing critical health challenges. His work continues to inspire advancements in treatment methodologies, paving the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…